Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaime E C Hallak

Showing results (61-70 of 129) with videos related to

Pageof 13
Sort By:
Frontiers in Psychiatry|July 5, 2021
Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural StudyDóra Révész, Genís Ona, Giordano N Rossi, et al.
Age and Ageing|June 14, 2013
Validation and internal consistency of Patient Health Questionnaire-9 for major depression in Parkinson's diseaseMarcos Hortes N Chagas, Vitor Tumas, Guilherme R Rodrigues, et al.
Journal of Psychoactive Drugs|February 9, 2019
Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca UsersGenís Ona, Maja Kohek, Tomàs Massaguer, et al.
Psychiatry Research. Neuroimaging|December 13, 2017
Brain functional and perfusional alterations in schizophrenia: an arterial spin labeling studyÍcaro A F Oliveira, Tiago M Guimarães, Roberto M Souza, et al.
Plos One|February 19, 2015
The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode networkFernanda Palhano-Fontes, Katia C Andrade, Luis F Tofoli, et al.
Journal of Clinical Psychopharmacology|July 15, 2024
Lack of Acute Agomelatine Effect in a Model of Social Anxiety in Healthy Volunteers: A Double-Blind, Placebo-Controlled TrialRafael G Dos Santos, Isabella C da Silva Dias, Antonio W Zuardi, et al.
Journal of Psychopharmacology (Oxford, England)|September 30, 2003
Olanzapine for recurrent aggression in a patient with temporal lobe epilepsy who had temporal lobectomyJaime E C Hallak, Serdar M Dursun, Ricardo Guarnieri, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 1, 2015
Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humansJosé Carlos Bouso, Fernanda Palhano-Fontes, Antoni Rodríguez-Fornells, et al.
CNS & Neurological Disorders Drug Targets|July 25, 2016
Role of Methylene Blue in Trauma Neuroprotection and Neuropsychiatric DiseasesMário Márcio Vasconcelos Batista-Filho, Ludmyla Kandratavicius, Emerson Arcoverde Nunes, et al.
Schizophrenia Research|January 15, 2015
Nitroprusside single-dose prevents the psychosis-like behavior induced by ketamine in rats for up to one weekJoao Paulo Maia-de-Oliveira, Bruno Lobão-Soares, Thais Ramalho, et al.
Pageof 13

Showing results (61-70 of 129) with videos related to

Sort By:
Pageof 13
Frontiers in Psychiatry|July 5, 2021
Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural StudyDóra Révész, Genís Ona, Giordano N Rossi, et al.
Age and Ageing|June 14, 2013
Validation and internal consistency of Patient Health Questionnaire-9 for major depression in Parkinson's diseaseMarcos Hortes N Chagas, Vitor Tumas, Guilherme R Rodrigues, et al.
Journal of Psychoactive Drugs|February 9, 2019
Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca UsersGenís Ona, Maja Kohek, Tomàs Massaguer, et al.
Psychiatry Research. Neuroimaging|December 13, 2017
Brain functional and perfusional alterations in schizophrenia: an arterial spin labeling studyÍcaro A F Oliveira, Tiago M Guimarães, Roberto M Souza, et al.
Plos One|February 19, 2015
The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode networkFernanda Palhano-Fontes, Katia C Andrade, Luis F Tofoli, et al.
Journal of Clinical Psychopharmacology|July 15, 2024
Lack of Acute Agomelatine Effect in a Model of Social Anxiety in Healthy Volunteers: A Double-Blind, Placebo-Controlled TrialRafael G Dos Santos, Isabella C da Silva Dias, Antonio W Zuardi, et al.
Journal of Psychopharmacology (Oxford, England)|September 30, 2003
Olanzapine for recurrent aggression in a patient with temporal lobe epilepsy who had temporal lobectomyJaime E C Hallak, Serdar M Dursun, Ricardo Guarnieri, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 1, 2015
Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humansJosé Carlos Bouso, Fernanda Palhano-Fontes, Antoni Rodríguez-Fornells, et al.
CNS & Neurological Disorders Drug Targets|July 25, 2016
Role of Methylene Blue in Trauma Neuroprotection and Neuropsychiatric DiseasesMário Márcio Vasconcelos Batista-Filho, Ludmyla Kandratavicius, Emerson Arcoverde Nunes, et al.
Schizophrenia Research|January 15, 2015
Nitroprusside single-dose prevents the psychosis-like behavior induced by ketamine in rats for up to one weekJoao Paulo Maia-de-Oliveira, Bruno Lobão-Soares, Thais Ramalho, et al.
Pageof 13